Rational therapy for renal cell carcinoma based on its genetic targets

Research output: Chapter in Book/Report/Conference proceedingChapter

6 Citations (Scopus)

Abstract

Renal cell carcinoma (RCC) is not a single entity, rather it is a term defining a group of histologically distinct tumors arising in the renal parenchyma. Each histologic subtype is clinically and genetically unique. It is our understanding of the genetic basis for these cancers that has led to the variety of targeted systemic therapies now available in RCC. This review will cover the basic tumor biology behind each histology, as well as the associated therapeutic targets identified thus far. Mechanisms and associated side effects of the currently available drugs will be examined. Completed clinical trials will be discussed, leading into the rationale behind currently active trials, and future directions for drug development.

Original languageEnglish (US)
Title of host publicationImpact of Genetic Targets on Cancer Therapy
EditorsWafik El-Deiry
Pages291-308
Number of pages18
DOIs
StatePublished - Feb 15 2013

Publication series

NameAdvances in Experimental Medicine and Biology
Volume779
ISSN (Print)0065-2598

Fingerprint

Renal Cell Carcinoma
Tumors
Cells
Histology
Pharmaceutical Preparations
Neoplasms
Therapeutics
Clinical Trials
Kidney
Direction compound

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Messer, J., Drabick, J., & Kaag, M. (2013). Rational therapy for renal cell carcinoma based on its genetic targets. In W. El-Deiry (Ed.), Impact of Genetic Targets on Cancer Therapy (pp. 291-308). (Advances in Experimental Medicine and Biology; Vol. 779). https://doi.org/10.1007/978-1-4614-6176-0-13
Messer, Jamie ; Drabick, Joseph ; Kaag, Matthew. / Rational therapy for renal cell carcinoma based on its genetic targets. Impact of Genetic Targets on Cancer Therapy. editor / Wafik El-Deiry. 2013. pp. 291-308 (Advances in Experimental Medicine and Biology).
@inbook{1d01358f75b546a085d30190cc66113e,
title = "Rational therapy for renal cell carcinoma based on its genetic targets",
abstract = "Renal cell carcinoma (RCC) is not a single entity, rather it is a term defining a group of histologically distinct tumors arising in the renal parenchyma. Each histologic subtype is clinically and genetically unique. It is our understanding of the genetic basis for these cancers that has led to the variety of targeted systemic therapies now available in RCC. This review will cover the basic tumor biology behind each histology, as well as the associated therapeutic targets identified thus far. Mechanisms and associated side effects of the currently available drugs will be examined. Completed clinical trials will be discussed, leading into the rationale behind currently active trials, and future directions for drug development.",
author = "Jamie Messer and Joseph Drabick and Matthew Kaag",
year = "2013",
month = "2",
day = "15",
doi = "10.1007/978-1-4614-6176-0-13",
language = "English (US)",
isbn = "9781461461753",
series = "Advances in Experimental Medicine and Biology",
pages = "291--308",
editor = "Wafik El-Deiry",
booktitle = "Impact of Genetic Targets on Cancer Therapy",

}

Messer, J, Drabick, J & Kaag, M 2013, Rational therapy for renal cell carcinoma based on its genetic targets. in W El-Deiry (ed.), Impact of Genetic Targets on Cancer Therapy. Advances in Experimental Medicine and Biology, vol. 779, pp. 291-308. https://doi.org/10.1007/978-1-4614-6176-0-13

Rational therapy for renal cell carcinoma based on its genetic targets. / Messer, Jamie; Drabick, Joseph; Kaag, Matthew.

Impact of Genetic Targets on Cancer Therapy. ed. / Wafik El-Deiry. 2013. p. 291-308 (Advances in Experimental Medicine and Biology; Vol. 779).

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Rational therapy for renal cell carcinoma based on its genetic targets

AU - Messer, Jamie

AU - Drabick, Joseph

AU - Kaag, Matthew

PY - 2013/2/15

Y1 - 2013/2/15

N2 - Renal cell carcinoma (RCC) is not a single entity, rather it is a term defining a group of histologically distinct tumors arising in the renal parenchyma. Each histologic subtype is clinically and genetically unique. It is our understanding of the genetic basis for these cancers that has led to the variety of targeted systemic therapies now available in RCC. This review will cover the basic tumor biology behind each histology, as well as the associated therapeutic targets identified thus far. Mechanisms and associated side effects of the currently available drugs will be examined. Completed clinical trials will be discussed, leading into the rationale behind currently active trials, and future directions for drug development.

AB - Renal cell carcinoma (RCC) is not a single entity, rather it is a term defining a group of histologically distinct tumors arising in the renal parenchyma. Each histologic subtype is clinically and genetically unique. It is our understanding of the genetic basis for these cancers that has led to the variety of targeted systemic therapies now available in RCC. This review will cover the basic tumor biology behind each histology, as well as the associated therapeutic targets identified thus far. Mechanisms and associated side effects of the currently available drugs will be examined. Completed clinical trials will be discussed, leading into the rationale behind currently active trials, and future directions for drug development.

UR - http://www.scopus.com/inward/record.url?scp=84873602698&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873602698&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-6176-0-13

DO - 10.1007/978-1-4614-6176-0-13

M3 - Chapter

C2 - 23288645

AN - SCOPUS:84873602698

SN - 9781461461753

T3 - Advances in Experimental Medicine and Biology

SP - 291

EP - 308

BT - Impact of Genetic Targets on Cancer Therapy

A2 - El-Deiry, Wafik

ER -

Messer J, Drabick J, Kaag M. Rational therapy for renal cell carcinoma based on its genetic targets. In El-Deiry W, editor, Impact of Genetic Targets on Cancer Therapy. 2013. p. 291-308. (Advances in Experimental Medicine and Biology). https://doi.org/10.1007/978-1-4614-6176-0-13